6 February 2018

On January 19, during the midwinter meeting of the Dutch Association of HIV Treatment Professionals, the Martijn Verbrugge Award 2017-2018 was awarded to Pauline Bollen, PhD candidate and hospital pharmacist, within the theme of Infectious diseases and global health.

Pauline received this award for the best abstract of original research on HIV-infected patients. The title of her lecture was: The pharmacokinetics and safety of dolutegravir in HIV-infected pregnant women. The preliminary results from this study show that the plasma concentrations of the new HIV drug dolutegravir do not change significantly during pregnancy, and that the application appears to be effective and safe. These results will contribute to the next update of international guidelines for treatment of HIV-positive women. The research is part of the PANNA network that is led by Dr Angela Colbers and Prof. David Burger (www.pannastudy.com).The award is named after Martijn Verbrugge, AIDS activist and former chairman of the Dutch HIV Association who died of AIDS in 2004.

Related news items


Frank Walboomers 25-years work anniversary at Radboudumc

17 September 2020

Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.

read more

Tjitske Kleefstra appointed endowed professor of Clinical genetics and psychopathology of rare syndromes

17 September 2020

Tjitske Kleefstra has been appointed endowed professor of Clinical genetics and psychopathology of rare syndromes at the department of Neurodevelopmental disorders, with effect from 1 September.

read more

Annette Schenck appointed professor of Translational Genetics

17 September 2020

Annette Schenck has been appointed professor of Translational Genetics at the department of Neurodevelopmental disorders, with effect from 1 August. The chair will bring together fundamental and translational research in the field of brain developmental disorders.

read more

Centuries-old medicine reduces the risk of new cardiovascular disease in heart patients

17 September 2020

Colchicine, an anti-inflammatory drug that has been used for gout for centuries, has been shown to prevent cardiovascular disease in patients who have had a heart attack or are suffering from narrowed coronary arteries. Results of the study are published in the New England Journal of Medicine.

read more

Radboudumc does large-scale research on systemic sclerosis

10 September 2020

In rare diseases, such as systemic sclerosis, it’s often difficult to conduct large-scale research. Rheumatologist Madelon Vonk has managed to follow enough patients with systemic sclerosis for years. The results of her research have been published in BMJ Annal of the Rheumatic Diseases.

read more